About Biom'Up
Biom'Up is a company based in Saint-priest (France) founded in 2005. Biom'Up has raised $43.82 million across 6 funding rounds from investors including Bpifrance, Gimv and European Union. Biom'Up operates in a competitive market with competitors including Prytime Medical Devices, Abyrx, LifeBond, Surgrx and Obsidio, among others.
- Headquarter Saint-priest, France
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$43.82 M (USD)
in 6 rounds
-
Latest Funding Round
$5.6 M (USD), Debt – Conventional
Aug 01, 2019
-
Investors
Bpifrance
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biom'Up
Biom'Up has successfully raised a total of $43.82M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5.6 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biom'Up
Biom'Up has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, Gimv and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Locked | Locked | Locked | |
|
Private equity firm
|
Locked | Locked | Locked | |
|
Smalt Capital is engaged in capital investment and renewable energy financing.
|
Locked | Locked | Locked |
Investor details for BiomUp
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biom'Up
Investment portfolio details for BiomUp
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BiomUp
Detailed financials for BiomUp
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biom'up Comparisons
Peer comparison for BiomUp
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biom'Up
Biom'Up operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prytime Medical Devices, Abyrx, LifeBond, Surgrx and Obsidio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of minimally invasive large vessel occludes for hemorrhage control in trauma patients
|
|
| Locked | Locked | Locked |
Hemostatic bone putty is developed for surgical bone bleeding control.
|
|
| Locked | Locked | Locked |
Absorbable surgical sealants and hemostats are developed for leakage prevention.
|
|
| Locked | Locked | Locked |
Tissue sealing and hemostasis systems are developed for laparoscopic surgery.
|
|
| Locked | Locked | Locked |
Shear-thinning biomaterial is developed to control blood flow minimally invasively.
|
Detailed competitors of BiomUp
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biom'up
Complete news archive for BiomUp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biom'Up
Biom'Up was founded in 2005 and raised its 1st funding round 7 years after it was founded.
Biom'Up is headquartered in Saint-priest, France. It is registered at Saint-priest, Auvergne-rhone-alpes, France.
Etienne Binant is the current CEO of Biom'Up.
Biom'Up is a funded company, having raised a total of $43.82M across 6 funding rounds to date.
BiomUp was founded in 2005 and is based in Saint Priest Bramefant, France. Operations are centered in the biotech sector, where hemostatic products for surgical use are developed. These include HEMOBLAST Bellows, an absorbable collagen-based material designed for biosurgery applications. Hemostasis is promoted, and surgical procedures are supported through these offerings. The focus remains on providing practical solutions for medical environments.
Biom'Up's top competitors include Prytime Medical Devices, Arch Therapeutics and LifeBond.
Biom'Up has 13 investors. Key investors include Bpifrance, Gimv, European Union, Athyrium Capital Management, and Sham.